UCL  IRIS
Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to https://www.ucl.ac.uk/finance/fiswebsite/contactinfo.htm
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
 More search options
Prof Linda Greensmith
504
UCL Institute of Neurology
Queen Square
London
WC1N 3BG
Appointment
  • Professor of Neuroscience
  • IoN Motor Neurosci & Mov Disorders
  • Institute of Neurology
  • Faculty of Brain Sciences
Research Summary

The research undertaken in our labs is focused on disorders that affect the neuromuscular system. In particular, our work is aimed at improving our understanding of the mechanisms involved in motor neuron degeneration and dysfunction in motor neuron diseases such as Amyotrophic Lateral Sclerosis (ALS) and Spinal Bulbar Muscular Atrophy (SBMA). We are also examining the pathological mechanisms underlying forms of peripheral neuropathy such as Charcot Marie Tooth Disease (CMT)/distal Hereditary Motor Neuropathy (dHMN). A key a pathological feature of these disorders is aberrant protein aggregation, and our interest in this pathological mechanism has led us to establish an active research programme investigating Inclusion Body Myositis (IBM), the most common muscle disorder affecting adults over the age of 50. Interestingly, mutations in the gene valosin containing protein (VCP) gene are a cause of both familial ALS as well as a hereditary form of IBM known as Inclusion body myopathy associated with Paget's disease and frontotemporal dementia (IBMPFD), linking IBM with ALS and FTD


We use a multidisciplinary approach in our experiments, examining motor neurons and muscle cells in culture (both primary cells and embroyonic stem cell-derived) as well as in animal models of neuromuscular disease. We also use a wide range of techniques from cellular and molecular biology to whole animal, in vivo systems physiology. This combination of techniques allows us to examine the molecular and cellular changes that take place in cells in culture under highly controllable conditions, which can help us to identify pathological mechanisms which we can then target with a range of potential therapeutic agents or approaches, before moving on to test the validity of our findings in vivo using appropriate animal models. The overall aim of our research program is to help in the development of effective therapeutic strategies for use in the treatment of these debilitating and often fatal neurodegenerative and neuromuscular disorders.

Academic Background
1989 PhD Doctor of Philosophy – Neuroscience University College London
1985 P.Grad Dip Postgraduate Diploma – Immunology Chelsea College
1984 BSc Hons Bachelor of Science (Honours) – Physiology University College London
Please report any queries concerning the data shown on this page to https://www.ucl.ac.uk/hr/helpdesk/helpdesk_web_form.php
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by